803 ORAL Analysis of Blood Plasma Factors in the AVITA Phase III Randomized Study of Bevacizumab (bev) With Gemcitabine-Erlotinib (GE) in Patients (pts) With Metastatic Pancreatic Cancer (mPC)
作者： E. Van Cutsem , G. Jayson , C. Dive , P. Dilba , S. de Haas
DOI: 10.1016/S0959-8049(11)70640-2
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(0)